Gail S. Page

Ms. Page is a diagnostics industry veteran with over 25 years executive experience, including commercialization, business development and general management of leading companies who are among Sword’s target customers.

In January 2013 Ms. Page founded Vineyard Investment Advisors. VIA is focused on partnering with entrepreneurs, businesses, and universities to transform their ideas into products and services. Prior to this venture, Ms. Page served as the President / CEO of Vermillion, Inc. from Jan 2006 thru December 2012. She was a member of the board from 2006 thru 2012 and served as Chairperson from 2010-2011. Vermillion is a healthcare company focused on developing and commercializing novel diagnostic blood test. Upon joining Vermillion in 2004 she inspired a pioneering spirit. Under her leadership the company was repositioned to embrace the progressive nature of its pipeline, successfully raised over $100M in funding, developed and commercially launched the first FDA-cleared blood test to help diagnose ovarian cancer. Ms. Page has spent her entire career in health care and has a passion for emerging technologies that advance the efforts in personalized medicine.